A niche blog dedicated to the issues that arise when supplementary protection certificates (SPCs) extend patents beyond their normal life -- and to the respective positions of patent owners, investors, competitors and consumers. The blog also addresses wider issues that may be of interest or use to those involved in the extension of patent rights. You can email The SPC Blog here

Tuesday 17 February 2009

Sitagliptin - NL - negative term

The SPC Blog recently reported the Netherland Patent Office's positive decision to grant an SPC for Sitagliptin. On that occasion, the Blog noted that a zero-term SPC was granted. However, after a more detailed look at the register (and the decision - the Blog isn't fluent in Dutch), it appears that the Netherland Patent Office granted an negative term SPC. So the score is now 2:3:1 (negative term SPC - UK and NL; rejected - PT, SI, DE; zero term SPC - GR) .

Let's see how the other patent offices decide.

No comments: